---
figid: PMC11010095__JAH3-13-e030054-g007
figtitle: The pivotal role of CTRP9 in reendothelialization of EPCs and the protective
  mechanisms of AMPK‐mediated Akt/eNOS signaling involved in adipoR1 and N‐cadherin
  receptor
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11010095
filename: JAH3-13-e030054-g007.jpg
figlink: /pmc/articles/PMC11010095/figure/jah39297-fig-0008/
number: F8
caption: Chronic exposure to HG impairs the reendothelialization capacity of EPCs.
  Treatment with gCTRP9 restores EPC functions and reendothelialization capacity under
  the HG environment through adipoR1 (not adipoR2) and N‐cadherin–mediated AMPK/Akt/eNOS
  pathway. adipoR1 indicates adiponectin receptor 1; adipoR2, adiponectin receptor
  2; Akt, protein kinase B; AMPK, AMP‐activated protein kinase; EC, endothelial cell;
  eNOS, endothelial nitric oxide synthase; EPC, endothelial progenitor cell; gCTRP9,
  globular C1q/tumor necrosis factor–related protein‐9; HG, high‐glucose; and VSMC,
  vascular smooth muscle cell.
papertitle: C1q/Tumor Necrosis Factor–Related Protein‐9 Is a Novel Vasculoprotective
  Cytokine That Restores High Glucose‐Suppressed Endothelial Progenitor Cell Functions
  by Activating the Endothelial Nitric Oxide Synthase.
reftext: Qingsong Hu, et al. J Am Heart Assoc. 2024 Feb 20;13(4):e030054.
year: '2024'
doi: 10.1161/JAHA.123.030054
journal_title: 'Journal of the American Heart Association: Cardiovascular and Cerebrovascular
  Disease'
journal_nlm_ta: J Am Heart Assoc
publisher_name: John Wiley and Sons Inc.
keywords: C1q/TNF‐related protein‐9 | diabetes | endothelial nitric oxide synthase
  (eNOS) | endothelial progenitor cells | high glucose | reendothelialization | Cell
  Therapy
automl_pathway: 0.9388593
figid_alias: PMC11010095__F8
figtype: Figure
redirect_from: /figures/PMC11010095__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11010095__JAH3-13-e030054-g007.html
  '@type': Dataset
  description: Chronic exposure to HG impairs the reendothelialization capacity of
    EPCs. Treatment with gCTRP9 restores EPC functions and reendothelialization capacity
    under the HG environment through adipoR1 (not adipoR2) and N‐cadherin–mediated
    AMPK/Akt/eNOS pathway. adipoR1 indicates adiponectin receptor 1; adipoR2, adiponectin
    receptor 2; Akt, protein kinase B; AMPK, AMP‐activated protein kinase; EC, endothelial
    cell; eNOS, endothelial nitric oxide synthase; EPC, endothelial progenitor cell;
    gCTRP9, globular C1q/tumor necrosis factor–related protein‐9; HG, high‐glucose;
    and VSMC, vascular smooth muscle cell.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - C1QTNF9
  - ADIPOR1
  - CDH2
  - ADIPOR2
  - AKT1
  - AKT2
  - AKT3
  - NOS3
  - ENO4
  - Hyperglycemia
---
